Colorectal cancer chemotherapy: irinotecan, Semin. Oncol, vol.27, pp.138-181, 2000. ,
Cellular roles of DNA topoisomerases: a molecular perspective, Nature Reviews Molecular Cell Biology, vol.351, issue.6, pp.430-470, 2002. ,
DOI : 10.1038/nrm831
Human DNA topoisomerase I: relaxation, roles, and damage control, Chromosoma, vol.32, issue.2, pp.75-85, 2005. ,
DOI : 10.1007/s00412-005-0345-5
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1400, issue.1-3, pp.83-105, 1998. ,
DOI : 10.1016/S0167-4781(98)00129-8
Phosphorylation of Histone H2AX and Activation of Mre11, Rad50, and Nbs1 in Response to Replication-dependent DNA Double-strand Breaks Induced by Mammalian DNA Topoisomerase I Cleavage Complexes, Journal of Biological Chemistry, vol.278, issue.22, pp.20303-20315, 2003. ,
DOI : 10.1074/jbc.M300198200
Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer Cells, Biochemical and Biophysical Research Communications, vol.280, issue.5, pp.1216-1239, 2001. ,
DOI : 10.1006/bbrc.2001.4267
ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases, International Journal of Cancer, vol.63, issue.6, pp.848-54, 2004. ,
DOI : 10.1002/ijc.20032
Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody, Cancer Res, vol.50, pp.6925-6955, 1990. ,
Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content, Oncol. Res, vol.4, pp.481-489, 1992. ,
Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance, Cancer Res, vol.57, pp.1516-1538, 1997. ,
Repair of and checkpoint response to topoisomerase I-mediated DNA damage, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.532, issue.1-2, pp.173-203, 2003. ,
DOI : 10.1016/j.mrfmmm.2003.08.016
Mechanisms of Camptothecin Resistance by Human Topoisomerase I Mutations, Journal of Molecular Biology, vol.339, issue.4, pp.773-84, 2004. ,
DOI : 10.1016/j.jmb.2004.03.077
Novel missense mutation of the DNA topoisomerase I gene in SN-38-resistant DLD-1 cells, Molecular Cancer Therapeutics, vol.5, issue.3, pp.502-510, 2006. ,
DOI : 10.1158/1535-7163.MCT-05-0246
Alters DNA Topoisomerase I Active Site Architecture and Sensitivity to Camptothecin, Journal of Biological Chemistry, vol.283, issue.6, pp.3305-3320, 2008. ,
DOI : 10.1074/jbc.M705781200
A single mutation in the 729 residue modulates human DNA topoisomerase IB DNA binding and drug resistance, Nucleic Acids Research, vol.36, issue.17, pp.5635-5679, 2008. ,
DOI : 10.1093/nar/gkn557
Topoisomerase I inhibitors: selectivity and cellular resistance, Drug Resistance Updates, vol.2, issue.5, pp.307-325, 1999. ,
DOI : 10.1054/drup.1999.0102
Single Mutation in the Linker Domain Confers Protein Flexibility and Camptothecin Resistance to Human Topoisomerase I, Journal of Biological Chemistry, vol.278, issue.44, pp.43268-75, 2003. ,
DOI : 10.1074/jbc.M303899200
No Alteration in DNA Topoisomerase I Gene Related to CPT-11 Resistance in Human Lung Cancer, Japanese Journal of Cancer Research, vol.14, issue.1470, pp.1280-1287, 1996. ,
DOI : 10.1111/j.1349-7006.1996.tb03144.x
Gene Mutation Analysis and Quantitation of DNA Topoisomerase I in Previously Untreated Non-small Cell Lung Carcinomas, Japanese Journal of Cancer Research, vol.54, issue.2, pp.160-165, 1997. ,
DOI : 10.1111/j.1349-7006.1997.tb00361.x
Point mutations in the topoisomerase I gene in patients with non-small cell lung cancer treated with irinotecan, Lung Cancer, vol.35, issue.3, pp.299-304, 2002. ,
DOI : 10.1016/S0169-5002(01)00425-1
Altered expression of cell proliferation-related and interferon-stimulated genes in colon cancer cells resistant to SN38, Cancer Biology & Therapy, vol.7, issue.6, pp.822-854, 2008. ,
DOI : 10.4161/cbt.7.6.5838
Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I, Cancer Res, vol.63, pp.8203-8214, 2003. ,
Analysis of topoisomerase I/DNA complexes in patients administered topotecan, Cancer Res, vol.55, pp.2097-103, 1995. ,
Molecular Cancer http://www.molecular-cancer.com/content, p.6464, 2011. ,
Dynamic Molecular Combing: Stretching the Whole Human Genome for High-Resolution Studies, Science, vol.277, issue.5331, pp.1518-1541, 1997. ,
DOI : 10.1126/science.277.5331.1518
The yeast Sgs1 helicase is differentially required for genomic and ribosomal DNA replication, The EMBO Journal, vol.22, issue.8, pp.1939-1988, 2003. ,
DOI : 10.1093/emboj/cdg180
Single-molecule analysis reveals clustering and epigenetic regulation of replication origins at the yeast rDNA locus, Genes & Development, vol.16, issue.19, pp.2479-84, 2002. ,
DOI : 10.1101/gad.232902
Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan, J Clin Oncol, vol.25, pp.773-80, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00147002
The Intra-S-Phase Checkpoint Affects both DNA Replication Initiation and Elongation: Single-Cell and -DNA Fiber Analyses, Molecular and Cellular Biology, vol.27, issue.16, pp.5806-5824, 2007. ,
DOI : 10.1128/MCB.02278-06
Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription, Nature Cell Biology, vol.20, issue.11, pp.1315-1339, 2009. ,
DOI : 10.1038/ncb1984
URL : https://hal.archives-ouvertes.fr/hal-00533325
High resolution melting applications for clinical laboratory medicine, Experimental and Molecular Pathology, vol.85, issue.1, pp.50-58, 2008. ,
DOI : 10.1016/j.yexmp.2008.03.012
Structural Flexibility in Human Topoisomerase I Revealed in Multiple Non-isomorphous Crystal Structures, Journal of Molecular Biology, vol.292, issue.3, pp.685-696, 1999. ,
DOI : 10.1006/jmbi.1999.3065
A Functional Linker in Human Topoisomerase I Is Required for Maximum Sensitivity to Camptothecin in a DNA Relaxation Assay, Journal of Biological Chemistry, vol.274, issue.46, pp.32950-60, 1999. ,
DOI : 10.1074/jbc.274.46.32950
Alterations in Linker Flexibility Suppress DNA Topoisomerase I Mutant-induced Cell Lethality, Journal of Biological Chemistry, vol.282, issue.13, pp.9855-64, 2007. ,
DOI : 10.1074/jbc.M608200200
Residue Arg621 stabilizes a hydrogen bond network in DNA topoisomerase I necessary for colon cancer cell sensitivity to irinotecan, Proc Am Assoc Cancer Res Denver, CO. Philadelphia, 2009. ,
The mechanism of topoisomerase I poisoning by a camptothecin analog, Proc. Natl. Acad. Sci, pp.15387-15392, 2002. ,
Mechanisms of Camptothecin Resistance by Human Topoisomerase I Mutations, Journal of Molecular Biology, vol.339, issue.4, pp.773-784, 2004. ,
DOI : 10.1016/j.jmb.2004.03.077